Status:
TERMINATED
LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Collaborating Sponsors:
Ortho Biotech, Inc.
Conditions:
T-Cell Lymphoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Peripheral T cell lymphoma and advanced cutaneous T cell lymphomas are aggressive and refractory diseases that are generally treated with chemotherapy. Despite current treatment modalities, only a sub...
Detailed Description
Peripheral T cell lymphoma and advanced cutaneous T cell lymphomas are aggressive and refractory diseases that are generally treated with chemotherapy. Despite current treatment modalities, only a sub...
Eligibility Criteria
Inclusion
- Inclusion:
- Patients must be at least 18 years of age. Histologically confirmed (including immunohistochemistry) diagnosis of T-Cell Lymphoma by skin biopsy or visceral/lymph node biopsy or bone marrow aspirate/biopsy Life expectancy of more than 3 months.
- Exclusion:
- Uncontrolled diabetes mellitus Active or serious infections uncontrolled with antibiotics Concurrent treatment, radiation or investigational treatment. 5.2.6 Significant underlying cardiac disease, including unstable angina, myocardial infarction less than 6 months before starting study, congestive failure of any cause
Exclusion
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2007
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00161239
Start Date
February 1 2005
End Date
October 1 2007
Last Update
December 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Institute of New Jersey
New Brunswick, New Jersey, United States, 08901